• Targeted Delivery of Amikacin into Mycobacterial Granulomas

  2026-07-29

  This study introduces a dendritic cell-mediated approach for the targeted delivery of amikacin into granulomas during Mycobacterium avium infection in mice. By conjugating amikacin to fluorescein isothiocyanate and loading it into dendritic cells, the research demonstrates effective local antibiotic delivery without increased systemic toxicity, suggesting a promising strategy for enhancing antibiotic efficacy in granulomatous infections.

• SNORA38B Drives NSCLC Progression and Immunotherapy Response

  2026-07-29

  This study reveals that SNORA38B, a small nucleolar RNA, acts as an oncogenic driver in non-small cell lung cancer (NSCLC) by promoting tumor growth and immune evasion through the GAB2/AKT/mTOR signaling pathway. Targeting SNORA38B not only suppresses tumorigenesis but also enhances the effectiveness of immune checkpoint blockade, highlighting its potential as both a prognostic biomarker and a therapeutic target.

• NVP-BGJ398 Phosphate: Mechanistic Advances in FGFR-Targeted

  2026-07-28

  Explore the scientific depth and translational promise of NVP-BGJ398 phosphate as a selective FGFR inhibitor. This article reveals unique mechanistic insights and practical assay guidance for cancer and skeletal disease research, setting it apart from prior protocol-focused content.

• ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-07-28

  This study uncovers ETS1 as a novel transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by targeting the SENP2/HSPA8/FUNDC1 axis, thereby inhibiting mitochondrial damage-induced autophagy. The findings reveal a mechanistic link between sumoylation-dependent mitophagy and neonatal lung injury, opening new avenues for targeted molecular interventions.

• Amikacin Sulfate: Advanced Intracellular Delivery in Researc

  2026-07-27

  Amikacin Sulfate, a potent aminoglycoside, is redefining antibiotic research with its robust intracellular uptake and targeted delivery—critical for models of non-tuberculous mycobacterial infection. This guide distills best practices, troubleshooting, and innovative workflows to harness Amikacin’s full experimental potential.

• Kanamycin Sulfate (SKU A2516): Data-Driven Solutions for Cel

  2026-07-27

  This article explores real laboratory challenges in cell viability and microbiology assays, highlighting how Kanamycin Sulfate (SKU A2516) from APExBIO addresses reproducibility, purity, and workflow reliability. Scenario-driven Q&A blocks provide evidence-based guidance, supporting researchers in selecting optimal antibiotic strategies for robust experimental outcomes.

• Kanamycin Sulfate in Precision Microbiology: Mechanisms, Ben

  2026-07-26

  Kanamycin Sulfate, a water-soluble antibiotic, is pivotal in modern microbiology and antibiotic resistance research. This article provides a unique, protocol-driven analysis of its assay-specific performance, practical handling, and evidence-backed selection strategies for researchers seeking deeper insight.

• N-MYC/eIF4G1 Axis Drives Survival in inv(16) AML via CBFβ-SM

  2026-07-25

  Peramangalam et al. uncover that N-MYC, regulated by a novel enhancer, sustains inv(16) acute myeloid leukemia cell survival through eIF4G1, revealing a unique mechanism linking the CBFβ-SMMHC oncoprotein to leukemic maintenance. These findings highlight new research avenues for targeting the N-MYC/eIF4G1 axis and provide a rationale for mechanism-focused acute myeloid leukemia research.

• NVP-BGJ398 Phosphate: Optimizing FGFR Inhibition in Applied

  2026-07-24

  NVP-BGJ398 phosphate stands out as a potent pan-FGFR inhibitor, enabling robust experimental advances in both oncology and skeletal disease models. This article delivers actionable workflows, troubleshooting strategies, and translational insights drawn from recent in vivo and in vitro breakthroughs.

• Danazol (Danocrine): Mechanisms and Research Protocol Guidan

  2026-07-24

  Danazol is a synthetic steroid with weak androgenic activity and established roles in inhibition of steroidogenesis and suppression of luteinizing hormone (LH). Its mechanistic effects and applications in endocrine research, including prostate cancer studies and hypothalamic–pituitary–gonadal (HPG) axis modeling, are well documented. This article provides protocol guidance, evidence review, and clarifies common misconceptions.

• T0070907: Precision PPARγ Antagonist for Pathway Dissection

  2026-07-23

  T0070907 delivers nanomolar precision as a PPARγ antagonist, enabling researchers to dissect adipogenesis, inflammation, and cell cycle regulation with unprecedented specificity. This guide details optimized workflows, troubleshooting strategies, and translational insights informed by the latest findings on the RXRα/PPARγ/NEDD4 axis.

• Hoechst 33342 Solution (1 mg/mL): Unveiling Nuclear Staining

  2026-07-23

  Explore how Hoechst 33342 nuclear stain advances live and fixed cell imaging, with a unique focus on mitochondrial quality studies and dermal fibroblast senescence. This in-depth guide integrates recent scientific breakthroughs to inform optimal assay design.

• G418 Sulfate (Geneticin): Advanced Selection and Antiviral U

  2026-07-22

  Geneticin (G418 Sulfate) stands out as a dual-purpose tool: a gold-standard antibiotic for genetic engineering selection and a potent inhibitor of Dengue virus serotype 2. This article unpacks practical protocols, experimental best practices, and recent insights connecting protein synthesis inhibition to emerging cancer and antiviral research.

• Kanamycin Sulfate: Precision Workflows for Antibiotic Resear

  2026-07-22

  Kanamycin Sulfate, a water-soluble antibiotic from APExBIO, sets the benchmark for reproducibility in antibiotic resistance research and microbiology workflows. Unlock robust experimental protocols, troubleshoot common pitfalls, and leverage insights from recent toxin inhibition studies to advance your anti-infection research.

• Acid-Responsive Nanomedicine Remodels Pancreatic Tumor Strom

  2026-07-21

  Fu et al. introduce a multistage, acid-responsive nanomedicine engineered to restore stromal homeostasis in pancreatic ductal adenocarcinoma. By sequentially releasing stroma-modulating agents and gemcitabine, this approach overcomes chemoresistance and achieves marked tumor regression in vivo.

16905 records 1/1127 page Next 12345 下5页 Last page